160 results
Page 3 of 8
6-K
EX-99
nmbjl
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
cy1fzw8t f1
3 Jun 20
Current report (foreign)
8:30am
424B5
x5r1i vt0x5c65f2tt43
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
2izder kl
28 May 20
Current report (foreign)
11:56am
6-K
EX-10.3
s36l9jeyevutqzmcfq4e
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
sh6ljw
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
8kzvm9ai pze
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
thaesbnj6m2dzzoo1h4
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
fj7vm
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99
hbjjk9mw p0
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
F-3
768kzkq
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-10.3
p8zlk wh56
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.2
ap9 tk15wy
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am